METLIFE INVESTS MORE THAN $8 BILLION IN PRIVATE PLACEMENTS DURING 2012
NEW YORK - March 11, 2013 - MetLife, Inc. (NYSE: MET) announced today that it, through MetLife Private Capital Investors, invested $8.1 billion in private securities during 2012. Active in the private market for over 90 years, the company is one of the largest private investors globally. MetLife manages over $54.0 billion, predominantly composed of its own account as well as assets for other institutions. Focusing on corporate, infrastructure and tax-credit investments, MetLife originates transactions worldwide and has holdings in 32 countries. The company's largest private investments are in the United States, the United Kingdom, Continental Europe and Australia.
"Private placement activity remained strong in 2012 and we worked closely with our customers to help meet their needs through a wide range of financings," said Scott Inglis, global head of MetLife Private Capital Investors. "MetLife remains one of the market's largest originators, thanks in large part to our scale and ability to invest across all major currencies. Our goal is to provide our institutional investors access to private fixed income assets with attractive risk-return profiles."
MetLife Private Capital Investors was also recognized for its infrastructure debt investment capabilities in 2012, being named 2012 "Global Institutional Investor of the Year" by Project Finance International magazine.
MetLife, Inc. is a leading global provider of insurance, annuities and employee benefit programs, serving 90 million customers. Through its subsidiaries and affiliates, MetLife holds leading market positions in the United States, Japan, Latin America, Asia, Europe and the Middle East. For more information, visit www.metlife.com.
Speeches, Testimony and Q&A
MetLife CEO Steve Kandarian in a major address on systemic risk says the federal government should focus on regulating risky activities not institutions.
MetLife Americas President William J. Wheeler testifies before Congress on systemic risk.